Alpha Tau Medical Ltd. Form 6-K Summary
Business context and reporting period
Alpha Tau Medical Ltd., an Israeli foreign private issuer, filed this Form 6-K on August 28, 2023. The filing covers interim consolidated financial statements as of June 30, 2023, and operating and financial review for the six months ended June 30, 2023.
Financial metrics
The provided filing text is limited to the Form 6-K cover page and does not include the attached financial statements or operating review. Accordingly, it does not provide clear values for revenue, profit or loss, cash flow, margins, debt, cash, liquidity, or other financial metrics.
Material changes versus the prior comparable period
The cover page identifies comparative interim financial statements for the six months ended June 30, 2022, but does not provide the underlying figures or a discussion of changes versus that period.
Guidance, outlook, risks, contingencies, and unusual items
No guidance, outlook, management commentary, risk discussion, contingencies, or unusual items are described in the provided text. These matters may be addressed in Exhibit 99.2, which is referenced but not included in the source content.
Important facts for investors to verify
- Review Exhibit 99.1 for the interim balance sheets, statements of operations, changes in shareholders’ equity, cash flows, and related notes.
- Review Exhibit 99.2 for management’s operating and financial review and prospects for the six months ended June 30, 2023.
- Verify cash balances, operating cash burn, liquidity runway, financing activity, debt obligations, and going-concern disclosures.
- Compare revenue, research and development expense, operating loss, net loss, and cash flows with the six months ended June 30, 2022.
- Note that the referenced exhibits are incorporated by reference into the company’s specified Form F-3 and Form S-8 registration statements.